Back

Plasma (1-3)-β-d-glucan levels are associated with host inflammatory responses and predict adverse clinical outcomes in critical illness

Kitsios, G. D.; Kotok, D.; Yang, H.; Finkelman, M.; Zhang, Y.; Britton, N.; Guo, R.; Evankovich, J. W.; Bain, W.; Shah, F.; Zhang, Y.; Benos, P. V.; McVerry, B. J.; Morris, A.

2020-06-12 intensive care and critical care medicine
10.1101/2020.06.11.20128264
Show abstract

BackgroundThe fungal cell-wall constituent (1,3)-{beta}-d-glucan (BDG) is a pathogen-associated molecular pattern (PAMP) that can stimulate innate immunity. We hypothesized that BDG from colonizing fungi in critically-ill patients may translocate into the systemic circulation and thus be associated with host inflammatory responses and outcomes. MethodsWe enrolled 453 mechanically-ventilated patients with acute respiratory failure with no evidence of invasive fungal infection (IFI). From serial plasma samples, we measured BDG, innate immunity and epithelial permeability biomarkers. From lower respiratory tract and stool samples we quantified bacterial and fungal DNA load using culture-independent techniques. ResultsA positive BDG test (>60pg/ml) at baseline was detected in 19% of patients. BDG levels were significantly associated with markers of innate immunity (interleukin-6, tumor necrosis factor receptor-1 and procalcitonin), epithelial barrier disruption (receptor for advanced glycation end-products and fatty-acid binding protein-2, for lung and gut respectively) and with higher probability of classification in an adverse prognosis hyperinflammatory subphenotype (all p<0.05). No differences in fungal or bacterial DNA load were found by BDG test positivity. Positive BDG testing was associated with higher incidence of acute kidney injury, fewer ventilator free days and worse 30-day survival (adjusted p<0.05). Patients with positive BDG test on follow-up sampling (>3 days from intubation) had higher mortality than patients with persistently negative test on follow-up (p<0.05). ConclusionsThis is the first study to demonstrate the prognostic role of BDG in critically ill patients with no evidence of IFI. Translocation of BDG into systemic circulation may contribute to inflammation and clinical outcomes. Funding supportNational Institutes of Health [K23 HL139987 (GDK); U01 HL098962 (AM); P01 HL114453 (BJM); R01 HL097376 (BJM); K24 HL123342 (AM); U01 HL137159 (DVM, PVB); R01 LM012087 (DVM, PVB); R01 HL142084 (JSL); R01 HL136143 (JSL); F32 HL137258 (JWE); F32 HL142172 (WB); K08 HS025455 (IJB); K23 GM122069 (FS)].

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Critical Care
based on 14 papers
Top 0.1%
16.1%
2
PLOS ONE
based on 1737 papers
Top 48%
10.6%
3
The Journal of Infectious Diseases
based on 137 papers
Top 0.3%
9.1%
4
Frontiers in Immunology
based on 140 papers
Top 0.7%
7.9%
5
European Respiratory Journal
based on 44 papers
Top 1%
5.5%
6
Critical Care Explorations
based on 15 papers
Top 0.4%
5.3%
50% of probability mass above
7
Frontiers in Medicine
based on 99 papers
Top 3%
4.7%
8
Scientific Reports
based on 701 papers
Top 48%
3.1%
9
American Journal of Respiratory and Critical Care Medicine
based on 23 papers
Top 0.7%
2.5%
10
JCI Insight
based on 63 papers
Top 3%
2.4%
11
Journal of Internal Medicine
based on 12 papers
Top 0.1%
2.4%
12
Frontiers in Cellular and Infection Microbiology
based on 22 papers
Top 1%
1.8%
13
iScience
based on 74 papers
Top 3%
1.6%
14
Biomedicines
based on 21 papers
Top 2%
1.4%
15
Journal of Clinical Medicine
based on 77 papers
Top 13%
1.2%
16
Journal of Personalized Medicine
based on 17 papers
Top 1%
1.2%
17
ERJ Open Research
based on 36 papers
Top 3%
0.8%
18
The Lancet Respiratory Medicine
based on 16 papers
Top 1%
0.8%
19
eBioMedicine
based on 82 papers
Top 6%
0.8%
20
BMJ Open
based on 553 papers
Top 49%
0.8%
21
Clinical Immunology
based on 12 papers
Top 1%
0.7%
22
Cells
based on 14 papers
Top 2%
0.7%
23
International Journal of Molecular Sciences
based on 39 papers
Top 4%
0.7%
24
Aging
based on 18 papers
Top 5%
0.7%